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The syndrome of inappropriate antidiuretic hormone secre-
tion is characterized by excessive water uptake and hypona-
tremia. The extent of hyponatremia, however, is less than
anticipated, which is ascribed to a defensemechanism, the vaso-
pressin-escape, and is suggested to involve a tonicity-deter-
mined down-regulation of the water channel aquaporin-2
(AQP2). The underlying mechanism, however, is poorly under-
stood. To study this, we used the mouse cortical collecting duct
(mpkCCD) cell line. MpkCCD cells, transfected with an AQP2-
promoter luciferase construct showed a reduced and increased
AQP2 abundance and transcription following culture in hypo-
tonic and hypertonic medium, respectively. This depended on
tonicity rather than osmolality and occurred independently of
the vasopressin analog dDAVP, cAMP levels, or protein kinase
A activity. Although prostaglandins and nitric oxide reduced
AQP2 abundance, inhibition of their synthesis did not influence
tonicity-induced AQP2 transcription. Also, cells in which the
cAMP or tonicity-responsive element (CRE/TonE) in the
AQP2-promoter were mutated showed a similar response to
hypotonicity. Instead, the tonicity-responsive elements were
pin-pointed to nucleotides283 to252 and157 to126 bp.
In conclusion, our data indicate that hypotonicity reduces
AQP2 abundance and transcription, which occurs indepen-
dently of vasopressin, cAMP, and the known TonE and CRE in
the AQP2-promoter. Increased prostaglandin and nitric oxide,
as found in vivo, may contribute to reduced AQP2 in vasopres-
sin-escape, but do not mediate the effect of hypotonicity on
AQP2 transcription. Our data suggest that two novel seg-
ments (283 to 252 and 157 to 126 bp) in the AQP2-
promoter mediate the hypotonicity-induced AQP2 down-
regulation during vasopressin-escape.
Renal water reabsorption is regulated by the hormone argi-
nine vasopressin (AVP).2 AVP binding to its V2 receptor in
renal principal cells induces a cAMP cascade leading to increased
translocationof thewater channel aquaporin-2 (AQP2) to the api-
calmembrane, resulting inwater reabsorption from the pro-urine
(1). In addition to this short-term effect, cAMP increases AQP2
transcription through phosphorylation of the transcription fac-
tor CREB (cAMP responsive element-binding protein), which
then binds to a cAMP responsive element (CRE) at210 in the
AQP2 promoter (2, 3). The increase in transcription is a more
long-term effect, requiring hours to take effect.
AVP synthesis and release are regulated by alterations in
plasma osmolality as well as non-osmotic, baroreceptor-medi-
ated pathways (4). Osmolality not only affects plasma AVP, but
also appears to have direct effects on urine concentrating ability
and AQP2 expression. In the syndrome of inappropriate anti-
diuretic hormone secretion (SIADH), for example, levels of
AVP are inappropriately high relative to plasma osmolality,
resulting in free-water retention and hypotonicity. Under these
circumstances, however, the free-water excretion is consider-
ably higher than would be expected from the vasopressin con-
centrations (5). This phenomenon, called the vasopressin-es-
cape, indicates that there are mechanisms counteracting
vasopressin action. In a rat animal model, it has been shown
that the onset of this escape coincides with a decrease in the
AQP2 expression in the renal collecting duct (6). Hypotonicity
and/or volume expansion have been proposed to mediate this
AVP-independent direct regulation of AQP2 expression (7).
Alternatively, an AVP-independent increase of AQP2 expres-
sion has been suggested to occur with hypertonicity. Valtin and
Edwards (8) already reported that water deprivation of vaso-
pressin-deficient Brattleboro rats leads to hypertonicity,
increased papillary interstitial osmolality, and concentration of
the urine. Similarly, Li et al. (9) found that hypertonicity due
to hyperglycemia or increased NaCl levels increases AQP2
expression in Brattleboro rats.
At present, it is still largely unknown how the AVP-inde-
pendent expression of AQP2 is regulated at themolecular level.
In mouse-collecting duct principal cells (mpkCCDc14), Hasler
et al. (10) showed that hypertonicity decreases the expression of
AQP2 in the short term, but increases its expression in the long
term. Here, hypertonicity did not affect the stability of AQP2
mRNA or protein, indicating that hypertonicity increases
AQP2 abundance by increasing its transcription.
One of the proteins suggested to be involved in the hyperto-
nicity response is the tonicity-responsive enhancer-binding
protein (TonEBP). This protein is up-regulated with hyperto-
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nicity in cultured cells and in the kidney medulla (11, 12) and
TonEBP knockdown or inhibition, but also mutation of its
tonicity-responsive element (TonE) in the AQP2 promoter,
reducedAQP2 expression inmpkCCD cells (13, 14).Moreover,
in TonEBP/ mice and mice transgenic for dominant-nega-
tive TonEBP, AQP2 expression was decreased (15, 16). How-
ever, the role of TonEBP and its TonE element inAQP2 expres-
sion regulation is still controversial. In Madin Darby Canine
Kidney (MDCK) cells, for example, Kasono et al. observed a
hypertonicity-induced increase in AQP2 transcription only
when the AQP2 promoter was6.1 kb or longer and therefore
did not involve TonE, which localizes at 489 bases upstream of
theAQP2 transcription start site (7).Moreover, the severe atro-
phy of the renal medulla in the TonEBP/ and dominant-
negative TonEBP-overexpressing mice complicates the inter-
pretation of its direct involvement in AQP2 regulation.
In addition to TonE, other promoter elements have been
suggested to be involved in hypertonicity-induced AQP2
expression, as Li et al. (14) reported that NFATc binding sites
downstream of TonE are also important for hypertonicity-in-
duced AQP2 expression in mpkCCD cells, because following
mutation of all five sites, hypertonicity-induced AQP2 expres-
sion was lost to a large extent.
Thus far, the effects of hypotonicity onAQP2 expression and
the underlying mechanisms have not been studied in great
detail. Thus, it is unclearwhether the regulatory changes during
hypotonicity mirror the regulation under hypertonic condi-
tions and involve changes in TonEBP or in the classical AVP-
cAMP signaling cascade elements. To decipher this, we tested
and used the mpkCCD cell line, which shows dDAVP-induced
expression of endogenous AQP2 (17).
EXPERIMENTAL PROCEDURES
Cell Culture—Mouse mpkCCDcl4 cells (18) were grown in a
modified defined medium (DMEM:Ham’s F12 1:1 v/v; 60 nM
sodium selenate, 5 g/ml transferrin, 2 mM glutamine, 50 nM
dexamethasone, 1 nM triiodothyronine, 10 ng/ml epidermal
growth factor, 5 g/ml insulin, 20 mM D-glucose, 2% fetal calf
serum, and 20 mM HEPES (pH 7.4)), resulting in a medium of
355mOsm.Cells were seeded at a density of 1.5 105 cells/cm2
on semi-permeable filters (Transwell, 0.4-mpore size, Corn-
ing Costar, Cambridge, MA) and cultured for 8 days. Unless
stated otherwise, the cells were treated for the last 96 h with 1
nM 1-deamino-8-D-arginine vasopressin (dDAVP) at the baso-
lateral side, to induce AQP2 expression. When used H89 (10
M, Calbiochem, San Diego, CA) was added to both the apical
and basolateral side. Tonicity was changed by adding solute to
NaCl-free defined medium (made identical to defined medium
used above). Tonicity was changed at both sides of the cells.
Osmolality was measured using a Knauer K-7400 semi-micro
osmometer (Berlin, Germany).
Constructs—To generate an AQP2 promoter-luciferase
reporter construct (pGL3-AQP2–3.0-luc), we first added the
neomycin selection marker to pGL3-basic (pGL3-neo). For
this, the neomycin cDNA preceded by an SV40 promoter was
cut from pcDNA 3.1 (Invitrogen) using XmnI and SalI, and
ligated into a blunted BamHI and SalI site of pGL3-basic (Pro-
mega). Next, a 3.3-kb fragment, containing the mouse AQP2
promoter (2970 to 60 upstream of the transcription start
site) was obtained by PCR using the primers GAAGATCTG-
GTCTGGGCCACGGGGGTGGCTCTTCC and GGTGCAC-
CGAGCCTCCTCCTCAGCC on mouse genomic DNA. Fol-
lowing digestion with BglII, which cuts the primer (restriction
site underlined) and at2970 in theAQP2 promoter, the prod-
uct was ligated into the BglII site upstream of the luciferase
cDNA in pGL3-neo.
For pGL3-AQP2–0.4-luc (containing 408 to 60 of the
AQP2 promoter), pGL3-AQP2–3.0-luc was cut with SacII and
KpnI, blunted, and religated. Constructs lacking 31-bp seg-
ments of the0.4 kb promoterweremade by 3 point PCRusing
different primers (Table 1) with pGL3-AQP2–0.4-luc as a tem-
plate. Mutations in CRE were introduced in pGL3-AQP2–0.4-
luc using site-directedmutagenesis (Stratagene) withmutagen-
esis primers listed in Table 1. This mutation has been shown to
inactivate theAQP2promoter (2).Mutations inTonE, reported
to reduce hypertonicity-inducedAQP2 transcription (13), were
introduced in pGL3-AQP2–3.0-luc using primers as shown in
Table 1. To generate pGL3-CRE(21)-luc, a DNA fragment con-
taining 21 CRE-elements was cut from pCRE121–3 (19) with SalI
and XhoI and ligated into the XhoI site of pGL3-neo. Proper ori-
entation and sequences were confirmed by sequence analysis.
MpkCCD cells were stably transfected using the calcium
phosphate precipitation technique as described (20). Trans-
fected colonies were selected with G418 (0.25 mg/ml) and
pooled to level out differences between individual colonies.
LuciferaseAssay—Luciferase activitywasmeasured using the
Luciferase Assay System (Promega) following the manufactur-
TABLE 1
Primers used to generate AQP2 promoter reporter constructs
Primer Forward primer (5-3) Reverse primer (5-3)
Deletion 1 (408 to377 bp) ggggtaccgtttggggtaaggcattg cgtcttccatggtggctttacc
Deletion 2 (377 to346 bp) ccacatttcctcacaagccttttagtc gactaaaaggcttgtgaggaaatgtgg
Deletion 3 (346 to315 bp) cttccttggccacagcctcctctgc cagaggaggctgtggccaaggaagg
Deletion 4 (315 to283 bp) aggtcactggactcattgtgggggctg agcccccacaatgagtccagtgaccttc
Deletion 5 (283 to252 bp) tggtgctggtgggctccatggggtaac taccccatggagcccaccagcaccag
Deletion 6 (252 to220 bp) cagccctgaggcaaaacagagacgtc gacgtctctgttttgcctcagggctgc
Deletion 7 (220 to189 bp) ctgaggaaaaaacgaggaattaatgaggag ctcctcattaattcctcgttttttcctcag
Deletion 8 (189 to157 bp) cttatctggagtccgctaagatggggtg caccccatcttagcggactccagataag
Deletion 9 (157 to126 bp) gtcagctgtgaaacaggagcagggatg catccctgctcctgtttcacagctgac
Deletion 10 (126 to95 bp) ttcgggtgggggggagcacagggttg aaccctgtgctcccccccacccgaag
Deletion 11 (95 to64 bp) aagtccgccatgccaccccacgtgc cacgtggggtggcatggcggacttg
Deletion 12 (64 to34 bp) caggaacgcctcctggccctataagtg cacttatagggccaggaggcgttcctg
Mutation CRE cgaggaaaacagagtggtcaatccttatctggagtcc ggactccagataaggattgaccactctgttttcctcg
Mutation TonE ccaagaccttttgccttttaaatttgtcccaggccagccag ctggctggcctgggacaaatttaaaaggcaaaaggtcttgg
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APRIL 15, 2011•VOLUME 286•NUMBER 15 JOURNAL OF BIOLOGICAL CHEMISTRY 13003
 at RA
D
BO
U
D
 U
N
IV
ERSITEIT N
IJM
EG
EN
 on A
pril 26, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
er’s instructions. Luminescence was measured for 10 s using an
EG&G Berthold Lumat LB9507 luminometer (Bad Wildbad,
Germany). To verify that equal amounts of protein per sample
were used for the luciferase assay, protein concentration was
determined using the Bio-Rad protein assay as described (21).
Light absorbance at 595 nmwasmeasured using a helios omega
spectrophotometer (Thermo Scientific, Rockford, IL).
Immunoblotting—mpkCCDcl4 cells from 1.13 cm2 filter were
lysed in 200l of Laemmli/DTT buffer, sonified, and incubated
for 30 min. at 37 °C. PAGE, blotting, and blocking of the PVDF
membranes were done as described (22). Membranes were
incubated overnight with 1:3000-diluted affinity-purified rab-
bit R7 AQP2 (23), 1:2000 rabbit CREB (Sigma) or 1:2000 rabbit
CREB-pS133 antibodies (Sigma) in Tris-buffered saline
Tween-20 (TBS-T) supplemented with 1% w/v nonfat dried
milk. Blots were incubated for 1 h with 1:5000-diluted goat
anti-rabbit IgGs (Sigma) as secondary antibody coupled
to horseradish peroxidase. Proteins were visualized using
enhanced chemiluminescence (ECL, Pierce). Densitrometric
analyses were performed using Bio-Rad quantification equip-
ment (Bio-Rad 690c densitometer, Chemidoc XRS) and soft-
ware (QuantityOne). Equal loading of the samples was con-
firmed by staining of the blots with Coomassie Blue G250
(Serva, Heidelberg, Germany).
cAMP Assay—MpkCCD cells were seeded on filters for 8
days, eitherwith orwithout 1 nMdDAVP for the last 4 days. The
last 24 h, cells were grown in hypotonic or isotonic medium.
The phosphodiesterase inhibitor 3-isobutyl 1 methylxanthine
(IBMX)was added to both the apical and basolateralmedium to
a final concentration of 500M 30min before harvesting. In the
cells grown without dDAVP, dDAVP was added to the basolat-
eral side 15 min before harvesting. cAMP was measured using
the cAMP-Glo assay (Promega) according to the manufactur-
er’s instructions.
Statistical Analyses—Student’s t test was applied to compare
two groups with Gaussian distribution. Levene’s test was used
to compare variances. p values below 0.05 were considered sig-
nificant. For multiple comparisons, Bonferroni correction was
applied.
RESULTS
mpkCCD Cells as a Model for Tonicity-induced AQP2
Expression—Hypertonicity has been shown to affect AQP2
transcription (10). To develop an easy readout cellular system
for AQP2 transcription and to test whethermpkCCD cells are a
proper cell model for these analyses, we generated pooled col-
onies of mpkCCD cells stably transfected with the pGl3-
AQP2–3.0-luc construct (mpkCCD-AQP2-luc), or a construct
lacking the AQP2 promoter (mpkCCD-luc). To first test
whether the promoter conferred vasopressin sensitivity, the
mpkCCD-AQP2-luc and mpkCCD-luc cells were grown on
semi-permeable filters for 8 days of which the last 4 dayswith or
without 1 nM dDAVP (17). Subsequent analysis revealed a 2.5-
fold higher luciferase activity in mpkCCD-AQP2-luc cells with
dDAVP than without dDAVP, while luciferase activity was
hardly observed inmpkCCD-luc cells (Fig. 1A). As endogenous
AQP2 abundancewas increased in both pooled colonies treated
with dDAVP (Fig. 1B), it was concluded that the dDAVP-in-
duced luciferase activity in mpkCCD-AQP2-luc cells is due
to AQP2 promoter-specific transcription. To test whether
changes in osmolality affect AQP2 expression in mpkCCD-
AQP2-luc cells, cells were grown for 8 days in isotonic medium
(120 mMNaCl; 355 mOsm/kg H2O). dDAVP was added during
the last 4 days. In the last 24 h, the cells were exposed to media
made hypotonic or hypertonic using different concentrations
of NaCl. Following lysis, immunoblotting revealed that a
decreased osmolality coincidedwith reducedAQP2 abundance
and vice versa (Fig. 1C). This was reflected in transcription from
the 3-kbAQP2 promoter luciferase reporter construct, because
luciferase activity increased with hyperosmolality and de-
creased with hypo-osmolality (Fig. 1D).
Changes in the concentration of NaCl affect both the osmo-
lality and tonicity. Todeterminewhether a change in osmolality
or in tonicity regulates AQP2 transcription in mpkCCD cells,
cells were grown and treated with dDAVP as described above.
Over the last 24 h, cells were incubated in hypotonic medium
FIGURE 1. mpkCCD cells as a model for tonicity-induced AQP2 expres-
sion. A and B, mpkCCD-AQP2-luc and mpkCCD-luc cells were grown to con-
fluence, the last 4 days with or without dDAVP. Cells were lysed and analyzed
for luciferase activity (A) or for AQP2 expression (B). Immunoblotting the
lysates for AQP2 revealed non-glycosylated (AQP2; 29 kDa) and complex-
glycosylated (g-AQP2; 40–45 kDa) AQP2 in lanes of mpkCCD cells treated
with dDAVP. Molecular mass (in kDa) is indicated on the left. C and D,
MpkCCD-AQP2-luc cells were grown to confluence and treated with 1 nM
dDAVP for 4 days. Over the last 24 h, cells were exposed to different osmola-
lities (indicated) using NaCl. Cells were lysed and analyzed for AQP2 expres-
sion (C) and luciferase activity (D). E, mpkCCD-AQP2-luc cells were grown as
above. During the last 24 h, cells were grown in hypo-osmotic medium, con-
taining 80 mM NaCl (hypo 275 mOsm), or medium with a osmolality of 355
mOsm, by adding NaCl, (Con) urea, sorbitol or sucrose (indicated). Cells were
lysed, and luciferase activity was determined. In all experiments above, the
meanvalues of luciferase activity per condition (S.E.)weredetermined from
three independent filters per condition. Significant differences (p 0.05) are
indicated by an asterisk.
Hypotonicity-induced Reduction of AQP2 Transcription
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(275 mOsm) or in a medium of 355 mOsm of which 80 mOsm
wasmade up by different solutes. Subsequent luciferase activity
measurements revealed that cell impermeant solutes such as
sorbitol and sucrosemimicked the effect ofNaCl, whereas a cell
permeant solute such as urea had no effect (Fig. 1E). Thus, these
data indicate that changes in tonicity, rather than osmolality,
affect AQP2 transcription in both directions and that the 3.0 kb
AQP2 promoter luciferase construct is a useful read-out sys-
tem. To simulate the in vivo situation of hyponatremia, NaCl
was used to change tonicity in all further experiments.
Does the Final or Change in Tonicity Determine AQP2
Expression?—At present, it is unclear whether the change in
tonicity or the tonicity itself determines AQP2 expression. To
test this, dDAVP-treated mpkCCD-AQP2–3.0-luc cells were
grown in medium of 355 or 275 mOsm for 8 days. In the last
24 h,mediumwas either unchanged or replaced by amediumof
the other osmolality. Analysis of the luciferase activity revealed
that under both conditions, AQP2 transcription was 2-fold
higher in cells grown for the last day in 355 versus 275 mOsm
medium (Fig. 2). These experiments clearly indicate that the
final, and not the change in tonicity, determines AQP2
expression.
Role of Nitric Oxide and Prostaglandins—Murase et al. (24)
reported that endogenous nitric oxide (NO) synthesis was sig-
nificantly increased in vasopressin-escape rats and that inhibi-
tion of NO synthesis with L-NAME decreased urine volume
and partially restored AQP2 expression. In addition, the excre-
tion of prostaglandin E2, which is known to reduce AVP-stim-
ulated water reabsorption in the collecting duct (25, 26), is
increased in vasopressin-escape and prevention of this increase
with the prostaglandin synthesis blocker indomethacin re-
sulted in a delay in the onset of escape (27). To test whether
inhibition of NO synthesis and prostaglandins directly affect
tonicity-induced changes in AQP2 expression, mpkCCD-
AQP2–3.0-luc cells were grown and treated with dDAVP as
above, but for the last 24 h changed to medium with different
osmolalities in the presence or absence of 10 M indomethacin
or 1 mM L-NAME. Immunoblot analysis of AQP2 levels
revealed that indomethacin and L-NAME treatment resulted in
increasedAQP2 protein expression levels (Fig. 3,A andB). This
increase with indomethacin and L-NAME was observed for
every tonicity tested. However, comparison of the AQP2 expres-
sion levels revealednodifferences in the tonicity responsebetween
control-, indomethacin-, or L-NAME-treated cells. Moreover,
AQP2-promoter-driven transcription of luciferase was not
changed with L-NAME or indomethacin at any of the tonicities
tested (Fig. 3C). These data indicate that, although NO and
prostaglandins decrease AQP2 abundance, they do not affect
tonicity-induced changes in AQP2 expression.
dDAVP Dependence of Tonicity-induced AQP2 Tran-
scription—Tonicity can change AQP2 abundance independent
of AVP in vivo (7, 9). To test whether an AVP-independent
effect of tonicity on AQP2 expression is also observed in our
cells,mpkCCD-AQP2–3.0-luc cells were again treatedwith dif-
FIGURE 2. The final tonicity, and not the change in tonicity, determines
the effect on AQP2 expression.mpkCCD-AQP2-luc cells were grown in iso-
tonic (355mOsm) or hypotonic (275mOsm) medium for 8 days. In both con-
ditions, cells were incubated in hypotonic or isotonicmediumduring the last
24 h. RLU, relative light units. Mean values of luciferase activity (S.E.) were
determined from three independent filters per condition.
FIGURE 3. Role of nitric oxide and prostaglandins in tonicity-regulated
AQP2 expression. A, mpkCCD-AQP2-luc cells were grown to confluence, the
last 4 days with dDAVP. Over the last 24 h, cells were exposed to different
osmolalities (indicated) in the absence or presence of indomethacin or
L-NAME, blockers for prostaglandin and nitric oxide synthesis, respectively.
Cells were lysed and analyzed for AQP2 abundance by immunoblotting. The
molecular mass (in kDa) is indicated on the left. B, relative abundances of
AQP2derived from:A, normalized for AQP2 abundance of control cells grown
under isotonic conditions. C, of samples as described above, luciferase activ-
ity was determined. Significant differences (p  0.05) are indicated by an
asterisk.
Hypotonicity-induced Reduction of AQP2 Transcription
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ferent NaCl concentrations for the last 24 h, but now in the
presence or absence of dDAVP for 4 days before harvesting.
Indeed, while luciferase levels were higher in samples treated
with dDAVP, the relative changes in luciferase activity with
changing tonicity in dDAVP-treated and -untreated samples
were similar (Fig. 4). These data show that inmpkCCDcells, the
effect of tonicity on AQP2 expression is independent of vaso-
pressin receptor stimulation.
TonE in Tonicity-induced AQP2 Transcription—Regulation
of AQP2 expression by tonicity through the TonE element,
located 489 bp upstream of the AQP2 transcription start site, is
controversial. To test the relevance of TonE in tonicity-affected
AQP2 expression under our conditions, we generated pooled
colonies of mpkCCD-AQP2–3.0-luc cells in which the TonE
element was inactivated as reported (13), and subjected these
and the mpkCCD-AQP2–3.0-luc cells to hypo- and hyperto-
nicity. Surprisingly, changing to hypotonic (275 mOsm) or
hypertonic (435 mOsm) medium revealed a similar change in
luciferase activity in the TonE mutants cells as found for
mpkCCD-AQP2–3.0-luc cells (Fig. 5A).
To further investigate this, we generated mpkCCD cells sta-
bly transfected with a construct in which luciferase expression
is driven by 408 bp of the AQP2 promoter, thus lacking the
TonE element (pGL3-AQP2–0.4-luc). Following subjection to
hypo- and hypertonicity, qualitatively similar changes in AQP2
transcription were found for the 3.0 and 0.4 kb promoter with
both changes (Fig. 5B). Combined, these data indicate that
TonE is not involved in the tonicity-induced regulation of
AQP2 expression under the present conditions. In addition,
our data suggest the presence of yet another tonicity-respon-
sive element in the 408-bp segment of the AQP2 promoter.
Role of CREB in Tonicity-induced AQP2 Transcription—In
this 408 bp segment is theCRE, located at position210, which
is involved in AVP-induced AQP2 transcription (2, 3). To test
whether CRE also has a role in tonicity-induced regulation of
AQP2, cells were stably transfected with pGL3-CRE(21)-luc, a
construct in which luciferase transcription is driven by a pro-
moter consisting of 21 tandemly placed CREs. Following
growth and incubation with dDAVP as above, a reduced lucif-
erase activity was observed with hypotonicity (Fig. 6A). From
this, we conclude that hypotonicity does decrease CRE-regu-
lated transcription.
As tonicity-regulated AQP2 expression appeared to be
AVP-independent (Fig. 4) while CRE-mediated transcrip-
tion is changed with hypotonicity (Fig. 6A), we investigated
which part of the AVP-cAMP-CREB-AQP2 promoter path-
way was involved.
As cAMP levels show a peak right after dDAVP addition, but
are reduced to low levels within 120 min following addition
(28), we tested the effect of hypotonicity on dDAVP-induced
cAMP levels in the long and short term. For the long term, cells
were grown as above, treatedwith dDAVP for 4 days, incubated
in hypotonic or isotonic medium during the last 24 h, and
treated with the phosphodiesterase inhibitor IBMX during the
last 30min. cAMP levelswere not changed by hypotonicity (Fig.
6B). To investigate whether there is an effect of hypotonicity
on short term cAMP generation, cells were grown without
dDAVP, incubated in hypotonic or isotonicmediumduring the
last 24 h, and subsequently treated with IBMX for the last 30
min andwith dDAVP for the last 15min. Analysis revealed that
the dDAVP-induced cAMP levels were not changed (Fig. 6B).
To test if the effect of tonicity on AQP2 transcription
involves protein kinase A (PKA), we tested whether the hypo-
tonicity-induced decrease in AQP2 transcription was still
observed when we would block PKA activity with H89, a PKA-
selective inhibitor. Cells were grown for 8 days and 24 h before
harvesting, medium was replaced with iso- or hypotonic
medium with dDAVP with or without 10 M H89. H89
decreased luciferase activity in cells grown in both iso- and
hypotonic medium, indicating that PKA is involved in AQP2
FIGURE 4. Role of dDAVP in tonicity-induced AQP2 transcription.
mpkCCD-AQP2-luc cells were grown as above, the last 4 dayswith or without
(Con) dDAVP. Over the last 24 h, cells were grown in isotonic or hypotonic
medium. After harvesting, luciferase activity was determined.
FIGURE 5. Role of TonE in tonicity-induced AQP2 transcription.mpkCCD
cells, stably transfected with a3.0 kb AQP2 promoter (Control) or the same
promoter, containing a mutated TonE sequence (mutTonE) (A), or together
withmpkCCDcells transfectedwith a0.4 kbAQP2promoter (B)weregrown
as above, where the last 24 h was in isotonic, hypertonic, or hypotonic
medium. Cells were lysed and subjected to luciferase activitymeasurements.
Mean values of luciferase activity (S.E.) were determined from three inde-
pendent filters per condition.
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transcription at both tonicities. However, the H89-induced
down-regulation of AQP2 transcription of about 30% was the
same for both tonicities (Fig. 6C), indicating that neither PKA,
nor cAMP or dDAVP are involved in the hypotonicity-induced
reduction in AQP2 transcription.
A tonicity-induced decrease in transcription can be caused
by a reduced CREB activity, which can be the result of a
decrease in total CREB and/or CREB phosphorylation at Ser-
133 (29). Indeed, immunoblotting showed a small, but signifi-
cant decrease in total and CREB-pS133 with hypotonicity (Fig.
FIGURE 6. Role of CREB in tonicity-induced AQP2 transcription. A, mpkCCD cells, stably transfected with a luciferase gene driven by amulti-CRE promoter,
weregrownasdescribedaboveandgrown for the lastday inhypotonicor isotonicmedium in thepresenceofdDAVP, lysed, andanalyzed for luciferaseactivity.
B, mpkCCD cells were grown as above and either pretreated with dDAVP for 4 days or only treated with dDAVP 15min before harvesting. In both conditions,
cells were cultured in hypotonic or isotonic medium over the last 24 h. After harvesting, cAMP levels weremeasured. C, mpkCCD cells, stably transfected with
a luciferase reporter construct containing 0.4 kbof theAQP2promoterwere grownas above. The last 24 h, cellswere treatedwith dDAVP and the PKA inhibitor
H89 (10 M) and grown in hypotonic or isotonic medium, lysed, and analyzed for luciferase activity. D, mpkCCD cells were grown as described under A. Cells
were lysed and subjected to immunoblotting for CREB and Ser-133-phosphorylated CREB (indicated). In the CREB-pS133-blot, the upper band represents
phosphorylated CREB, whereas the lower band represents ATF-1, which is also recognized by this antibody. Molecular masses (in kDa) are indicated on
the left. E, relative abundance of total and Ser-133-phosphorylated CREB derived from Fig. 6D and normalized for their expression in isotonic medium.
F, mpkCCD cells stably transfected with constructs encoding luciferase and preceded by the 0.4 kb AQP2 promoter (Con) or the same promoter,
containing a mutated CRE sequence (mutCRE), were grown as above, with or without dDAVP and the last 24 h in hypotonic or isotonic medium. After
harvesting, luciferase activity was determined. Mean values (S.E.) were determined from three independent filters per condition. Significant differ-
ences (p  0.05) are indicated by an asterisk.
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6,D and E). The relative changes in total andCREB-pS133were
similar, indicating that the decrease in CREB-pS133 is due to
the decrease in total CREB.
To investigate the role of the CRE element in the AQP2 pro-
moter, mpkCCD cells were stably transfected with the pGL3-
AQP2–0.4-luc construct in which the CRE element was inac-
tivated. Subsequently, these andmpkCCD-AQP2–0.4-luc cells
were subjected to the hypotonicity assay with or without
dDAVP. As anticipated, dDAVP treatment increased luciferase
activity significantly in mpkCCD-AQP2–0.4-luc cells, but not
in cells containing the CRE mutant (Fig. 6F). In both cell mod-
els, however, hypotonicity led to a similar decrease in luciferase
activity, which indicated that the AQP2 CRE element is not
essential for the response to hypotonicity.
AQP2 Promoter Segments Involved in the Decreased Tran-
scription under Hypotonic Conditions—Because the CRE in the
AQP2 promoter was shown not to be essential for the hypoto-
nicity effect (Fig. 6F), we further analyzed the 0.4kb AQP2
promoter for the hypotonicity element by generating twelve
AQP2 promoter deletion constructs in which in each 31 bp
(three rounds of the DNA helix) was deleted (Fig. 7A), leaving
the relative orientation of the transcription factor binding sites
intact. Cells stably transfected with these constructs were
tested for their response to 24 h of hypotonicity in the presence
of dDAVP. While most cells with these constructs yielded sig-
nificantly reduced luciferase activity with hypotonicity, lucifer-
ase activity was not significantly reduced in cells containing
constructs lacking nucleotides 284 to 254 (segment No. 5)
and158 to127 (No. 9) (Fig. 7B).
DISCUSSION
mpkCCDCells Are a ProperModel to Study Tonicity-induced
Regulation of AQP2 Expression—Our data reveal thatmpkCCD
cells are a proper model to study hyper- and hypotonicity-in-
duced changes inAQP2 expression and transcription. First, fol-
lowing transfection of a luciferase reporter construct preceded
by a 3.0 kbAQP2promoter, we showed that dDAVP induced an
increase in AQP2 protein expression as well as transcription in
mpkCCD cells (Fig. 1, A and B). This illustrated that the 3.0 kb
promoter of AQP2 is sufficient for the response to dDAVP and
is consistent with data of others using the human AQP2 pro-
moter of a similar length in other cells (2, 3, 30, 31). Secondly,
both AQP2 protein expression and transcription were in-
creased with hypertonicity (Fig. 1, C and D), which is in line
with the hypertonicity-induced increased AQP2 protein
expression shown in vivo (9) and in vitro (10).
We also observed a down-regulation of AQP2 in response to
hypotonicity in vitro. This down-regulation of AQP2 was pre-
vented when re-adjusting osmolality with sorbitol, sucrose, or
NaCl, but not urea (Fig. 1E). It is therefore tonicity, and not
osmolality, that affectsAQP2 expression, which is in agreement
with previous results (10). Besides, we showed that the final
tonicity and not the change in tonicity determined the extent of
AQP2 transcription (Fig. 2).
Hypotonicity-induced AQP2 Down-regulation Is Indepen-
dent of dDAVP, Prostaglandins, and Nitric Oxide Production—
Similar to in vivo and other in vitro studies with hypertonicity
(7, 9), we show that the hypotonicity-induced decrease inAQP2
expression is independent of dDAVP, as the relative effects of
hypotonicity were similar in the absence or presence of dDAVP
(Fig. 4).
We investigated this further. Hypotonicity did not affect the
cAMP-PKA pathway, as cAMP levels were not changed by
hypotonicity and PKA blockade with H89 had no effect on the
hypotonicity-induced down-regulation of AQP2. The decrease
in luciferase activity in cells treated with H89 shows that this
drug was still active (Fig. 6C).
Interestingly, hypotonicity significantly decreased luciferase
activity in cells possessing several CRE elements coupled to the
luciferase cDNA (Fig. 6A), indicating that tonicity does affect
CRE-mediated transcription. This decrease can be attributed to
a decrease in total CREB protein levels, whichwas similar to the
fractional decrease in CREB phosphorylation on serine 133
(Fig. 6,D and E). CRE, however, appeared not to be essential for
the tonicity response of AQP2 expression, because mutating or
deleting the CRE sequence in the AQP2 promoter had no effect
on the tonicity-mediated AQP2 transcription (Figs. 6F and 7).
Considering the observed reduced expression of luciferase with
hypotonicity from the CRE-luciferase construct, it may be that
the 21 tandemly placed CREs in this construct makes it more
sensitive to detect CRE-mediated transcription than the AQP2
promoter. Alternatively, hypotonicity-regulated expression of
AQP2 gene transcription is dominated by transcription factor
binding sites other than itsCRE. In either case, our data indicate
that the CRE element in the AQP2 promoter is irrelevant for
the reduced transcription of the AQP2 gene with hypotonicity,
which is in linewith our data that cAMP levels and PKA activity
are not changed with hypotonicity (Fig. 6, A–C) and with the
findings of our group and others that the effect of tonicity is
AVP independent.
A candidate involved in the cellular signaling leading to the
hypotonicity-mediated decrease in AQP2 transcription is NO,
FIGURE 7. AQP2 promoter segments involved in hypotonicity response.
A, position of the 31-bp segments deleted from the AQP2 promoter in rela-
tion to the transcription start site. B, mpkCCD cells stably transfected with a
0.4 kb AQP2 promoter construct, containing deletions as indicated in A,
were grown as above. The last 24 h, cells were grown in hypotonic or isotonic
medium. After harvesting, luciferase activity was determined. The relative
luciferase activity is normalized for differences in transfection efficiencies by
dividing the values obtained in the hypotonic medium by the values
obtained in the isotonic medium.
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as it has been shown that NO decreases AQP2 expression (32,
33) and renal NO synthase expression correlates inversely with
medullary tonicity (34, 35). Similarly, Murase et al. (24) found
that endogenous NO synthesis was significantly increased in
the vasopressin-escape animals and that treatment with
L-NAME decreased urine volume and partially increased
AQP2 expression. In agreement with this, blockingNO synthe-
sis by L-NAME resulted in increased AQP2 protein abundance
inmpkCCD cells (Fig. 3A). L-NAMEdid not however affect the
tonicity-mediated change in AQP2 abundance (Fig. 3B). More-
over, the tonicity-induced changes in AQP2 transcription were
not changed with L-NAME (Fig. 3C). These data reveal that,
although NO decreases AQP2 abundance in mpkCCD cells,
NOdoes not affectAQP2 gene transcription and is not involved
in the tonicity-regulated change in AQP2 expression.
Another mechanism involved might be an increased prosta-
glandin production. Prostaglandin E2 is known to reduce AVP-
stimulated water reabsorption in the collecting duct (25, 26).
Moreover, Gross et al. (27) showed an increased urinary pros-
taglandin E2 excretion in vasopressin-escape, and preventing
this increase with indomethacin resulted in a delay in the onset
of escape. In agreement with these data, blocking prostaglandin
production with indomethacin resulted in an increased AQP2
protein expression in ourmpkCCDcells (Fig. 3A). No effectwas
seen on AQP2 promoter-driven luciferase activity, however,
indicating that the decrease of AQP2 abundance with prosta-
glandins occurs at the protein or mRNA stability level, rather
than AQP2 gene transcription. In addition and similar to the
effect of L-NAME, indomethacin treatment did not affect the
tonicity-induced AQP2 expression, suggesting that prostaglan-
din production is not affected by tonicity, and is not involved in
the tonicity-regulated expression of AQP2.
In the context of the in vivo data, our data indicate that
paracrine-produced increased levels of prostaglandins
and/or NO in the kidney may indeed contribute to the
reduced AQP2 abundance observed in vasopressin-escape
animals, but that they cannot explain the effect of tonicity on
AQP2 gene transcription.
Tonicity-induced AQP2 Transcription Is TonE Independent—
The role of TonE in tonicity-regulatedAQP2 expression is con-
troversial. In our experiments, the TonE in the AQP2 promoter
was not important for AQP2 transcription regulation by tonic-
ity, because: 1) introduction of a TonEmutation identical to the
mutation introduced by Hasler et al. in a 3.0 kb AQP2 pro-
moter had no effect on tonicity-induced AQP2-transcription
(Fig. 5A) and 2) luciferase activity obtained from the 0.4 kb
AQP2 promoter, which lacks TonE, and the3.0 kb promoter
were similarly influenced by the different tonicities used to cul-
ture the cells in (Fig. 5B).
Our data are in contrast to those obtained byHasler et al. (13)
who used the same cell model, but under different conditions.
Growing cells for only 2 days, where the last day was in serum-
free medium and without dDAVP stimulation, Hasler et al.
found an absence of the hypertonicity-induced AQP2-pro-
moter driven luciferase activity in mpkCCD cells when the
TonE element was mutated. We tested whether this could be
due to different experimental conditions. Indeed, growing cells
in the same way, we saw a significant reduction, but not com-
plete absence, in hypertonicity-induced luciferase activity in
the TonE mutant cells compared with the mpkCCD-AQP2–
3.0-luc cells (not shown). This difference was caused by the
shorter growth period, as growing the cells for 8 days, the last
24 h with hypertonic serum-free medium without dDAVP, did
not show any difference in the hypertonic response between the
promoters with an intact or mutated TonE element (not
shown). As in our experience, mpkCCD cells are only polarized
after 4 days of culture (not shown), growing the cells for 8 days,
as used in our experiments, better mimics the in vivo situation.
Our data seem in contrast to in vivo data, as TonEBP/
mice and mice transgenic for dominant-negative TonEBP
showed decreased AQP2 expression (15, 16). However, the
severe atrophy of the renal medulla in the TonEBP/ and
dominant-negative TonEBP-overexpressing mice complicates
the interpretation of the direct involvement of TonE in tonicity
regulation of AQP2 expression. To resolve this apparent dis-
crepancy, investigation of the role of TonE and TonEBP in a
conditional knock-out mouse in which the structure of the
renal medulla would be intact is needed.
Segments from 283 to 252 and 157 to 126 bp of the
AQP2 Promoter Are Involved in Hypotonicity-induced AQP2
Down-regulation—Using a 0.4 kb promoter, hypo- and
hypertonicity showed qualitatively similar changes in AQP2
transcription as compared with the 3.0 promoter (Fig. 5B),
indicating that a tonicity responsive element is present in the
408 bp AQP2 promoter. With subsequent segment deletions,
the location of this TonE element could be pinpointed to two 31
bp promoter segments (5 and 9) in the 0.4 kb AQP2 pro-
moter, covering nucleotides283 to252 and157 to126
bp.
Li et al. (14) reported that the effect of hypertonicity on
AQP2 transcription depends on NFATc sites in the AQP2 pro-
moter. The NFATc sites tested by Li et al. are localized in seg-
ments 1, 6, and 7 of the 0.4 kb promoter. Two segments are
located more upstream; one of them representing the TonE
sequence. In our experiments, neither the upstream segments,
nor segments 1, 6, or 7 appeared important in the hypotonicity
response. One explanation for this difference could be the dif-
ferences in experimental conditions, as Li et al. used unpolar-
ized mpkCCD cells and looked at an effect of tonicity after 6 h.
This time period of subjection to a changed tonicity indeed
seems of relevance, because Hasler et al. (10) have shown that
the response to a change in tonicitywithin 3 h is opposite to that
obtained after 24 h. Another explanation could be that in the
experiments performed by Li et al. all the NFATc sites were
mutated simultaneously, while we only deleted one or two sites
at once. The inactivation of multiple NFATc sites could influ-
ence the tonicity effect, whereas deletion of only one or two
sites may be too small a change to detect.
To possibly identify the transcription factors involved, seg-
ments 5 and 9 were analyzed for potential transcription factor
binding sites using TRANSFAC databases (36). In segment 5,
binding sites for nuclear factor B (NF-B) and SP1 were iden-
tified, and in segment 9, aGATAbinding site was found (Fig. 8).
Based on the literature, these transcription factors could
mediate the change in AQP2 gene transcription with tonicity,
as a study in intestinal epithelial cells suggest activation of
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NF-B and stimulation of NF-B-mediated transcription by
osmotic stress (37). Similarly, hypertonicity activates NF-B
in renal medullary interstitial cells, and water deprivation
increases renal NF-B-driven reporter gene expression in
transgenic mice (38). In addition, GATA may play a role in
tonicity-regulated AQP2 transcription, because hypertonic
stress induces transcription of GATA-2 in placental tropho-
blast stem cells (39). It remains to be established whether these
transcription factors and their promoter elements are respon-
sible for the tonicity effect on AQP2 transcription.
In conclusion, we showed that in mpkCCD cells, tonicity-
induced AQP2 expression is mediated by transcription factors
other than TonEBP or CREB and that it occurs in an AVP-
independent manner. The tonicity responsiveness seems to
involve AQP2 promoter segments covering nucleotides 283
to252 and157 to126 bp of the AQP2 promoter. Identi-
fication of transcription factors and signaling proteins involved
in hypotonicity-regulatedAQP2 expression in follow-up exper-
iments will provide us better insights into physiological regula-
tion of AQP2 expression and renal water reabsorption by tonic-
ity and may lead to the discovery of targets for modulation of
pathophysiological conditions of osmoregulation, such as with
SIADH.
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FIGURE 8. Transcription factor binding sites. Transcription factor binding
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